About us Pricing ContactSubscribe

L

Luis Paz‐Ares

Hospital Universitario 12 De OctubreORCID https://orcid.org/0000-0002-1947-3364

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

New England Journal of Medicine20158,491 citations

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

The Lancet Oncology20125,500 citations

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

The Lancet Oncology20191,690 citations

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

The Lancet Oncology20211,333 citationsFirst authorCorresponding

Luis Paz‐Ares · Scinovex